Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rheumatic diseases in pregnancy.

N S Nicholas1

  • 1Queen Charlotte's Hospital, London.

British Journal of Hospital Medicine
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Pregnancy impacts rheumatic diseases unpredictably. Managing disease activity during pregnancy requires balancing maternal health with potential fetal risks from medications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is there synchronicity in nitrogen input and output fluxes at the Noland Divide Watershed, a small N-saturated forested catchment in the Great Smoky Mountains National Park?

TheScientificWorldJournal·2003
Same author

Dendrochemical analysis of lead and calcium in southern Appalachian American beech.

Journal of environmental quality·2002
Same author

Rheumatoid arthritis and pregnancy.

Clinical and experimental rheumatology·1988
Same author

The effects of pregnancy on the rheumatic diseases.

British journal of rheumatology·1987
Same author

Immunosuppressive properties of pregnancy serum on the mixed lymphocyte reaction.

British journal of obstetrics and gynaecology·1986
Same author

Human retroplacental sera inhibit the expression of class II major histocompatibility antigens.

Journal of reproductive immunology·1986

Area of Science:

  • Rheumatology
  • Obstetrics
  • Pharmacology

Background:

  • Rheumatic diseases present unique challenges during pregnancy.
  • Disease activity significantly influences pregnancy outcomes.
  • Medication use necessitates careful risk-benefit assessment.

Purpose of the Study:

  • To review the complexities of managing rheumatic diseases in pregnant patients.
  • To discuss the interplay between disease activity, pregnancy, and drug safety.
  • To highlight the dilemmas faced in clinical decision-making.

Main Methods:

  • Literature review of studies on rheumatic diseases and pregnancy.
  • Analysis of clinical data regarding disease course and fetal outcomes.
  • Evaluation of teratogenic risks associated with common drug regimens.

Related Experiment Videos

Main Results:

  • Pregnancy outcomes are closely linked to the severity of rheumatic disease at conception.
  • The choice of medication involves weighing known teratogenic risks against the dangers of uncontrolled disease.
  • Unpredictable disease flares can complicate management strategies.

Conclusions:

  • Effective management requires individualized treatment plans for pregnant women with rheumatic conditions.
  • Close collaboration between rheumatologists and obstetricians is crucial.
  • Further research is needed to optimize drug safety and efficacy during pregnancy.